Highlights Cosmos Health Inc.

Stocks

COSM

US2214133058

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:49:20 2026-07-13 am EDT			5-day change	1st Jan Change
0.3270 ^USD	+11.72%		+20.01%	-34.96%

Jul. 02	Cosmos Health Expands Share Buyback to 3.4 Million Shares	MT
Jun. 30	Cosmos Health Inc. announces an Equity Buyback for $5 million worth of its shares.	CI

Highlights

Jul. 10	Cosmos Health Inc. Launches Subscription-Based Purchasing Model for Its Proprietary Consumer Health Brands	CI
Jul. 07	Cosmos Health Inc. Provides Preliminary Revenue Guidance for the Second Quarter and First Half 2026	CI
Jul. 02	Cosmos Health Expands Share Buyback to 3.4 Million Shares	MT
Jun. 30	Cosmos Health Inc. announces an Equity Buyback for $5 million worth of its shares.	CI
Jun. 29	Cosmos Health Inc. authorizes a Buyback Plan.	CI
Jun. 26	Cosmos Health Signs Qatar Distribution Deal With IMC	MT
Jun. 26	Cosmos Health Inc. Signs Distribution Agreement with International Medical Company, and Secures Initial Purchase Order of 31,000 Sky Premium Life Units	CI
Jun. 18	Cosmos Health Inc. Expands AI Automation and Facility Capacity	CI
Jun. 17	Cosmos Health Launches Premium Korean-Developed Collagen-Based Skincare Brand in the United States	CI
Jun. 15	Cosmos Health Introduces Four 18 Series Products with Projected Annualized Revenue and Gross Profit in the United States	CI
Jun. 11	Cosmos Health Signs Letter of Intent to Buy Doc Pharma	MT
Jun. 10	Cosmos Health Inc. has entered into a non-binding letter of intent to acquire DOC Pharma SA.	CI
Jun. 10	Cosmos Health Unit Signs 3-Year Manufacturing Deal With Verisfield	MT
Jun. 08	Cosmos Health Unit Acquires Patent Application From Cloudpharm	MT
Jun. 05	Cosmos Health Inc. Announces U.S. Launch of Oliv18 Targeting Cardiovascular and Antioxidant Categories	CI
Jun. 01	Cosmos Health Inc. Enters USD 69 Billion Global Animal Health Industry With Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 And EN 1657	CI
May. 26	Cosmos Health targets $200 mln revenue, $44 mln adjusted EBITDA by 2029	RE
May. 26	Cosmos Health Inc. Provides Earnings Guidance for the Year 2026, 2027, 2028 and 2029	CI
May. 20	Cosmos Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 15	Cosmos Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Apr. 13	Cosmos Health Gets New 60,000-Unit Sky Premium Life Order From Pharmalink	MT
Mar. 19	Cosmos Health Says It May Use Noncore Assets to Help Fund Future Plans	MT
Feb. 18	Cosmos Health Continues Uk Retail Expansion for C-Scrub; Now Available At Superdrug, the Uk?S Second-Largest Beauty and Health Retailer	CI
Feb. 17	Cosmos Health Showcases Expanding Brand Portfolio At World Health Expo Dubai 2026	CI
Dec. 03	Cosmos Health Inc. Launches Strategic Partnership with Prime Ledger LLC to Transform $300 Million Treasury and Tokenize IP Assets	CI